Study of QL2106 for moderate to severe plaque psoriasis
Part of Skin clinical trials.
This trial tests an injectable drug, QL2106, for people with moderate to severe plaque psoriasis. It may help if you are a candidate for light therapy or other systemic treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have plaque psoriasis (with or without psoriatic arthritis).
- Your psoriasis covers at least 10% of your body.
- Your psoriasis severity score (PASI) is 12 or higher.
- Your doctor's overall assessment (IGA) is at least 3.
- You are eligible for light therapy or systemic treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This study tests an experimental drug, SHR-1139, given as an injection, to see if it can help people with plaque psoriasis who haven't gotten enough relief from other biologic treatments. It aims to improve skin symptoms and quality of life.
This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.
This study tests a new injectable medicine for people with moderate-to-severe plaque psoriasis. It aims to see if it is safe and effective at reducing symptoms like redness and scaling.
This trial tests an oral medication called TQH3906 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve skin symptoms and is for adults who have not had enough success with other treatments.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.